Full name
BIOTECHNOLOGY CONSULTING AND INVESTMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
BIOTECHNOLOGY CONSULTING AND INVESTMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
BRODY 32, 68-343 BRODY
TAX ID9282078287
Rate company:
BIOTECHNOLOGY CONSULTING AND INVESTMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9282078287
KRS0000480883
Share capital5,000.00 zł
address
BRODY 32, 68-343 BRODY
Website
[email protected]Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9282078287
REGON
081169500
KRS
0000480883
Legal form
limited liability company
Register Address
BRODY 32, 68-343 BRODY
Date of registration in KRS
2013-10-17
Date of commencement of economic activity
2013-10-17
Act signature
RDF/627825/24/580
Website
Pkd codes
72.11.Z - Research and experimental development on biotechnology
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
64.20.Z - Activities of holding companies
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
70.22.Z - Business and other management consultancy activities
71.12.Z - Engineering activities and related technical consultancy
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
86.90.E - Other human health activities notelsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL20 1240 6768 1111 0010 5489 4324 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0 | -0 | -0 | 31,3 |
EBITDA | 0 | -0 | -0 | 31,3 |
Short time liabilities | 1 | 1 | 1 | -0 |
Equity capital | 0,6 | 0,6 | 0,6 | -0,5 |
Operating profit (EBIT) | 0 | -0 | -0 | 31,3 |
Assets | 1,6 | 1,6 | 1,6 | -0,2 |
Net profit (loss) | 0 | -0 | -0 | 31,3 |
Cash | 0 | 0 | 0 | -16,5 |
Net income from sale | 0 | 0 | 0 | 950 |
Liabilities and provisions for liabilities | 1 | 1 | 1 | -0 |
Working assets | 1,6 | 1,6 | 1,6 | -0,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0 | -0,7 | -0,5 | 0,2 |
Equity capital to total assets | 39,5 | 39,5 | 39,3 | -0,2 |
Gross profit margin | 5,5 | -4567,1 | -298,7 | 4268,4 |
EBITDA Margin | 5,5 | -4567,1 | -298,7 | 4268,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 765 | 3 468 998 | 330 332 | -3 138 666 |
Current financial liquidity indicator | 1.66021728515625 | 1.6518336534500122 | 1.648629903793335 | -0,1 |
Net dept to EBITDA | -18.791635513305664 | 1.2722300291061401 | 1.546682357788086 | 0,2 |
Financial statements
01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download doc01-01-2023 - 31-12-2023
Annual financial report
Download doc01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.